Catalyst Wire Dossier Catalyst Wire Dossier

BFB-101

AAV9-AP4B1 gene therapy · BlackfinBio Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BFB-101, covering 2025-04-28 to 2025-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) [Phase 1, Phase 2]

See pricing